bylvay
(odevixibat)Ipsen Biopharmaceuticals, Inc.
Usage: BYLVAY is indicated for treating pruritus in patients 3 months and older with Progressive Familial Intrahepatic Cholestasis (PFIC) and cholestatic pruritus in patients 12 months and older with Alagille Syndrome (ALGS). Note: it may not be effective for all PFIC type 2 patients.